Kiran Mazumdar-Shaw of Biocon secured the fourth spot with Rs 29,330 crore, making a mark of India’s biotech and healthcare ...

September yields at least 23 listing applications from mainland biotech firms eyeing the city’s lucrative fundraising market.

The US stock market showed mostly small gains today despite a government shutdown. The Dow, S&P 500, and Nasdaq all rose, led by strong tech stocks. Investors stayed hopeful the shutdown wont last and ...

If the U.S. stays on its current path, it will surrender its biotech lead not because China wins, but because Washington quits.

Harmony Biosciences Holdings (HRMY) is in the spotlight after announcing that its Phase 3 RECONNECT study for ZYN002 in Fragile X syndrome did not meet its main goal, citing higher than expected ...

Englewood biotech SpotitEarly partners with Hackensack Meridian to study AI and canine-powered breath tests for early cancer ...

Irish biotech start-up Aerska has raised $21 million (€18 million) in seed funding to help develop ribonucleic acid-based ...

AbCellera (ABCL) has pivoted to in-house drug development, with two Phase 1 assets and a recent share price surge despite ...

University of Bristol biotech spin-out company Cirrus Therapeutics has today (Thursday 2 October) announced the close of an ...

Nanobiotix (NASDAQ:NBTX) traded higher on Thursday after the French biotech announced initial results from a Phase 1 trial ...